Geron (GERN) Amortization of Deferred Charges (2019 - 2026)

Geron's (GERN) quarterly Amortization of Deferred Charges came in at $286000.0 in Q1 2026, up 13.04% year-on-year from $253000.0 in Q1 2025, and up 1.06% quarter-over-quarter from $283000.0 in Q4 2025.

Geron (GERN) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends

Geron has disclosed Amortization of Deferred Charges across 8 years of filings, most recently posting $286000.0 for Q1 2026.

  • Amortization of Deferred Charges for Q1 2026 came in at $286000.0, up 13.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 130.19% YoY), and the FY2025 annual result was $1.1 million, up 134.46% from the prior year.
  • Amortization of Deferred Charges came in at $286000.0 for Q1 2026 at Geron, up from $283000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $802000.0 in Q1 2024 to a low of -$5.0 million in Q4 2024.
  • The 5-year median for Amortization of Deferred Charges is $283000.0 (2025), against an average of $39058.8.
  • Peak annual rise in Amortization of Deferred Charges reached 231.4% in 2024, while the deepest fall reached 1545.66% in 2024.
  • Geron's Amortization of Deferred Charges stood at $224000.0 in 2022, then soared by 54.46% to $346000.0 in 2023, then sank by 1545.66% to -$5.0 million in 2024, then soared by 105.66% to $283000.0 in 2025, then gained by 1.06% to $286000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $286000.0 (Q1 2026), $283000.0 (Q4 2025), and $273000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Geron 729,618.77 729,618.77 -

Historic Data

Download Data
DateValue
Mar 31, 2026 286,000.00
Mar 31, 2026 286,000.00
Dec 31, 2025 283,000.00
Dec 31, 2025 283,000.00
Sep 30, 2025 273,000.00
Sep 30, 2025 273,000.00
Jun 30, 2025 262,000.00
Jun 30, 2025 262,000.00
Mar 31, 2025 253,000.00
Mar 31, 2025 253,000.00
Dec 31, 2024 -5.00 Mn
Dec 31, 2024 -5.00 Mn
Sep 30, 2024 402,000.00
Sep 30, 2024 402,000.00
Jun 30, 2024 690,000.00
Jun 30, 2024 690,000.00
Mar 31, 2024 802,000.00
Mar 31, 2024 802,000.00
Dec 31, 2023 346,000.00
Dec 31, 2023 346,000.00